For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices for cardiologists to evaluate and manage patients who have heart attacks with no significant signs of coronary artery disease — a condition known as myocardial infarction with non-obstructive coronary arteries (MINOCA). The new document, published in the March 27 issue of Circulation,1 aims to help physicians better recognize patients with this condition, to avoid common misdiagnoses and streamline care. It is especially important for women, who represent a disproportionate number of MINOCA cases.

Foreign-trained doctors now make up one-third of cardiologists in the United States and help make up for the U.S. overall shortage of physicians. Pictured here is co-author of this article Mandeep R. Mehra, MBBS, MSc, FRCP, who is an example of the contribution international physicians have made in the U.S. He is medical director of the Brigham and Women’s Hospital Heart and Vascular Center.

As we strive to process today’s successive news cycles involving negative reports about immigration, it is easy for many to assume that international physicians are a new phenomenon in the United States ― and a problematic one at that. Predictions of a physician shortage are now mainstream news. The immigration debate in recent years has heightened awareness of the individuals who enter our country and their reasons for coming here. And nationalist sentiments reinforce fears that our prestige and quality of life will suffer from welcoming others to the United States.

April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack Endovascular System. This is a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease (PAD).

April 15, 2019 — Biotronik began its U.S. commercial launch of the PK Papyrus covered coronary stent system for use in the emergency treatment of acute coronary perforations.[1,2]

Now available in the United States, the PK Papyrus is the first FDA-approved device for the treatment of acute perforations in nearly two decades. More than 800,000 percutaneous coronary intervention (PCI) procedures are performed annually in the U.S. and fewer than 8,000 require a covered stent, classifying PK Papyrus as a Humanitarian Use Device.[3] 

Despite national guidelines indicating statins can lower risk of heart attack and stroke, many patients who could benefit do not take them. More than half of eligible patients say they were never offered the cholesterol-lowering drugs; the experience of side effects or fear of side effects were reasons for stopping or refusing statins, according to new research in Journal of the American Heart Association.

International Conference & Exhibition on Cardiology and Cardiovascular Medicine

Complex Cardiovascular Catheter Therapeutics (C3)

The 15th Annual Complex Cardiovascular Catheter Therapeutics: Advanced Endovascular and Coronary Intervention Global Summit (C3)! C3celebrates its’ 15 year anniversary this June 23 - 26, 2019 in Orlando, Florida at the Hilton Bonnet Creek. 

The Amputation Prevention Symposium (AMP)

This meeting is dedicated to the transcatheter treatment of clitical limb ischemia (CLI).

This week, cardiologists learned for the first time they have been examining black holes for decades and did not know it. Many cardiologists and radiologists did a double take when they saw the ground-breaking first image of a black hole released by the U.S. National Science Foundation.

ACC Latin America Conference

United by our shared commitment of transforming cardiovascular care, the American College of Cardiology (ACC) and Colombian Society of Cardiology and Cardiovascular Surgery (SCC) invite you to join us for an innovative educational experience that will strengthen your everyday practice.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now